Attention-Deficit Hyperactivity Disorder (ADHD)

AACAP ADHD

AACAP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/55268

Contents of this Issue

Navigation

Page 10 of 11

Maximum/Day Comments 40 mg > Short-acting stimulants often used as initial treatment in small children (< 16 kg), but have disadvantage of bid-tid dosing to control symptoms throughout day. > Longer-acting stimulants offer greater convenience, confidentiality, and compliance with single daily dosing, but may have greater problematic effects on evening appetite and sleep. > Adderall XR cap may be opened and sprinkled on soft food. 30 mg 40 mg 70 mg FDA 20 mg 30 mg > Short-acting stimulants often used as initial treatment in small children (< 16 kg), but have disadvantage of bid-tid dosing to control symptoms throughout day. 60 mg 60 mg > Longer-acting stimulants offer greater convenience, confidentiality, and compliance with single daily dosing, but may have greater problematic effects on evening appetite and sleep. > Metadate CD, Ritalin LA, and Focalin XR may be opened and sprinkled on soft food. > Concerta tab should be swallowed whole with liquids. > Concerta nonabsorbable tab shell may be seen in stool. 72 mg 30 mg Lesser of 1.4 mg/kg or 100 mg > Consider if active substance abuse or severe side effects of stimulants (mood liability, tics). > Give q am or divided doses bid (effects on late evening behavior). 0.4 mg 4 mg 9 > Do not open cap. > Monitor closely for suicidal thinking and behavior, clinical worsening, or unusual changes in behavior. > Not a Schedule II medication. > Taper when discontinuing — 0.1 mg q3-7d

Articles in this issue

Archives of this issue

view archives of Attention-Deficit Hyperactivity Disorder (ADHD) - AACAP ADHD